Alexis Cruz, MD | |
605 S Conroe Medical Dr, Conroe, TX 77304-4722 | |
(936) 539-4004 | |
(936) 521-3964 |
Full Name | Alexis Cruz |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 605 S Conroe Medical Dr, Conroe, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194306639 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | U2182 (Texas) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | BP10074825 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alexis Cruz, MD 605 S Conroe Medical Dr, Conroe, TX 77304-4722 Ph: (936) 539-4004 | Alexis Cruz, MD 605 S Conroe Medical Dr, Conroe, TX 77304-4722 Ph: (936) 539-4004 |
News Archive
America's employers, small and large, are taking better care of their employees with managed healthcare partnerships. Many organizations offer wellness options for workers including health screenings for various diseases, fitness programs to help people get in shape, and on-call health and wellness coaches.
Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just that.
Policymakers and public health experts have long recognized the harm that can come to fetuses if women use drugs during pregnancy.
The cortical response to esophageal, stomach or rectal stimulation has been studied using several different modalities including evoked potentials, functional magnetic resonance imaging (fMRI), and positron emission tomography. However, there is no information concerning the cerebral cortical response to sensory signals that originate in the biliary tract in humans.
As three pharma majors, Pfizer Inc with partner BioNTech SE, Moderna Inc. and AstraZeneca Plc announced this month the effectiveness of their experimental vaccines in preventing COVID-19, there were no guarantees that developing countries will get their fair share.
› Verified 9 days ago